Zoetis (ZTS) Net Income towards Common Stockholders Growth (5y) (2017 - 2026)
Powered by 
Analysis
Zoetis (ZTS) Net Income towards Common Stockholders Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.64 Bn | 40.44 Bn | 779.09 Mn |
| 2 | Zoetis | 30.58 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.37% |
| Mar 31, 2026 | 1.99% |
| Dec 31, 2025 | 12.62% |
| Sep 30, 2025 | 8.24% |
| Jun 30, 2025 | 13.60% |
| Mar 31, 2025 | 9.24% |
| Dec 31, 2024 | 10.87% |
| Sep 30, 2024 | 15.08% |
| Jun 30, 2024 | 16.02% |
| Mar 31, 2024 | 19.08% |
| Dec 31, 2023 | 9.23% |
| Sep 30, 2023 | 15.62% |
| Jun 30, 2023 | 17.95% |
| Mar 31, 2023 | 14.77% |
| Dec 31, 2022 | 6.60% |
| Sep 30, 2022 | 17.64% |
| Jun 30, 2022 | 22.09% |
| Mar 31, 2022 | 24.92% |
| Dec 31, 2021 | 16.98% |
| Sep 30, 2021 | 22.70% |